As of May 24
| +0.50 / +1.56%|
The 12 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 41.50, with a high estimate of 48.00 and a low estimate of 30.00. The median estimate represents a +27.22% increase from the last price of 32.62.
The current consensus among 13 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.